Scott A. Gangloff - Chief Technology Officer at Akero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Technology Officer
Stock Symbol
AKRO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Scott A. Gangloff since 4/23/2024

Holdings reported by Scott A. Gangloff for Akero Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 24.3K $756K $31.10 Dec 16, 2024 Direct
Stock Option (Right to Buy) 73.7K Dec 16, 2024 Direct Common Stock

Transactions reported by Scott A. Gangloff for Akero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.